This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM (IRAKLIA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05405166
Recruitment Status : Recruiting
First Posted : June 6, 2022
Last Update Posted : January 31, 2024
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 23, 2024
Estimated Study Completion Date : February 15, 2027